Genetic and Functional Identification of Cardiovagal Nucleus Ambiguus Neurons
Authors: Jalil Maira , Coverdell Tatiana , Abbott Stephen , Campbell John 
Published: May 2023

Heart rate is an important physiological index of overall health and is primarily controlled by the parasympathetic nervous system, which suppresses heart rate at rest and during cardiac reflexes. The nucleus ambiguus (nAmb), a region found within the brainstem, is a primary source of parasympathetic input to the heart. It also innervates striated muscles of the larynx, pharynx, and esophagus to regulate the motor function of speech and swallowing. To identify candidate cardiovagal neurons and differentiate them from neighboring motor neurons, we profiled genome-wide RNA expression in ~1,250 nAmb neurons by single nuclei RNA-sequencing. Clustering these neurons based on their transcriptomic similarity revealed six candidate molecular subtypes, which we annotated according to their subtype-specific marker genes. Based on their gene expression profiles, we hypothesized that three subtypes may be cardiovagal neurons. Three other subtypes, marked by Vipr2 or Crhr2 expression, likely correspond to the neurons that innervate the upper airways and esophagus, as shown by our previous work. Two of the three potential cardiovagal subtypes were specifically marked by their expression of Vip and Adcyap1, respectively, and the other subtype co-expressed Npy2r and Adcyap1. Fluorescence RNA in situ hybridization validated that Npy2r and Adcyap1 transcripts mark partially overlapping nAmb neurons residing throughout its rostrocaudal axis. To determine whether these neuron subtypes can control heart rate, we targeted expression of a calcium-translocating channelrhodopsin variant (CatCh) to the Npy2r+ and Adcyap1+ nAmb neuron subtypes using intersectional genetics. We then activated CatCh+ neuron subtypes using laser light transmitted via a fiber optic implanted over the nAmb and measured the effect on heart rate (HR) in awake, behaving mice. Our results show an immediate and dramatic decrease in HR upon activation of Npy2r+nAmb neurons (n=6 Npy2r-Cre:Chat-Flp:CatCh mice; laser-on HR= 58 ± 17% of laser-off HR; p<0.0001), or Adcyap1+nAmb neurons (n=5 Adcyap1-Cre:Chat-Flp:CatCh mice; laser-on HR= 34 ± 13% of laser-off HR; p<0.0001). The HR decrease depended on the frequency of stimulation (n=3 mice per genotype) and was not observed in the absence of CatCh expression (n=4 mice; laser-on HR = 100 ± 0% of laser-off HR; p>0.05). Blocking muscarinic receptors with atropine prevented the bradycardic effect of activating Npy2r+nAmb neurons (n=5 mice), suggesting a parasympathetic mechanism. These results indicate that Npy2r+nAmb neurons and Adcyap1+nAmb neurons are capable of suppressing HR, which builds on our previous observation of bradycardia when activating all nAmb neurons but not when activating the upper airway and esophageal projecting subtypes (recently published) Vipr2+nAmb neurons and Crhr2+nAmb neurons, respectively. Together, our results identify cardiovagal neuron subtypes in the nAmb based on their molecular and functional properties.

The authors gratefully acknowledge Maisie Crook for her technical assistance. Funding was provided by National Institutes for Health (NIH) F31 HL158187 to T.C.C.; NIH R01 HL148004 to S.B.G.A.; and an American Diabetes Association Pathway to Stop Diabetes Initiator Award 1-18-INI-14 and NIH R01 HL153916 to J.N.C.

This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.